GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Amyris Inc (FRA:3A01) » Definitions » Other Operating Expense

Amyris (FRA:3A01) Other Operating Expense : €-0.0 Mil (TTM As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is Amyris Other Operating Expense?

Amyris's Other Operating Expense for the three months ended in Mar. 2023 was €-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.0 Mil.

Amyris's quarterly Other Operating Expense increased from Sep. 2022 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then declined from Dec. 2022 (€0.0 Mil) to Mar. 2023 (€-0.0 Mil).

Amyris's annual Other Operating Expense declined from Dec. 2020 (€0.0 Mil) to Dec. 2021 (€-0.0 Mil) but then increased from Dec. 2021 (€-0.0 Mil) to Dec. 2022 (€0.0 Mil).


Amyris Other Operating Expense Historical Data

The historical data trend for Amyris's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amyris Other Operating Expense Chart

Amyris Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amyris Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Amyris Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amyris Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Amyris's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Amyris (FRA:3A01) Business Description

Traded in Other Exchanges
Address
5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.

Amyris (FRA:3A01) Headlines

No Headlines